1)日本胃癌学会(編).胃癌治療ガイドライン,第6版.金原出版,2021
2)田辺聡,石戸謙次,松本主之,他.胃癌ESD後の局所遺残再発例,転移再発例の臨床病理学的特徴と経過・予後—多施設共同研究.胃と腸 49:1601-1608, 2014
3)笹子三津留,木下平,丸山圭一.早期胃癌の予後.胃と腸 28:139-146, 1993
4)日本胃癌学会(編).胃癌取扱い規約,第15版.金原出版,2017
5)山澤翔,牛久哲男.胃:胎児消化管類似癌・肝様腺癌.胃と腸 55:421-424, 2020
6)Murakami T, Yao T, Mitomi H, et al. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation:a study of 29 cases. Gastric Cancer 19:498-507, 2016
7)夕部由規謙,石橋雄次,小平佳典,他.胃原発胎児消化管上皮類似癌の2例.日臨外会誌 78:2652-2657, 2017
8)小沢俊文,奥山裕子,奥村浩二,他.急速な形態変化とともにAFP値の上昇をきたした早期胃癌の1例.Gastroenterol Endosc 40:1864-1871, 1998
9)Chang YC, Nagasue N, Abe S, et al. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87:321-325, 1992
10)Kinjo T, Taniguchi H, Kushima R, et al. Histologic and immunohistochemical analysis of α-fetoprotein-producing cancer of the stomach. Am J Surg Pathol 36:56-65, 2012
11)Ushiku T, Shinozaki A, Shibahara J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. AM J Surg Pathol 34:533-540, 2010
12)中島寛隆,山﨑琢士,尾割道代,他.早期胃癌の深達度診断—X線造影像を用いた深達度診断.胃と腸 50:593-601, 2015
13)伴慎一.大腸T1癌内視鏡的切除標本の正しい取り扱いと病理組織診断—脈管侵襲評価のポイントとピットフォール.胃と腸 56:1083-1091, 2021